Enanta Pharmaceuticals Inc. buy Westpark Capital
Start price
30.09.25
/
50%
€10.60
Target price
30.09.26
€23.89
Performance (%)
-14.62%
Price
22.10.25
€8.90
Summary
This prediction is currently active. The price of Enanta Pharmaceuticals Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -14.62%. This prediction currently runs until 30.09.26. The prediction end date can be changed by Westpark_Capital at any time. Westpark_Capital has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
Enanta Pharmaceuticals Inc. | 1.622% |
iShares Core DAX® | 0.299% |
iShares Nasdaq 100 | 2.257% |
iShares Nikkei 225® | 5.054% |
iShares S&P 500 | 1.414% |
Comments by Westpark_Capital for this prediction
In the thread Enanta Pharmaceuticals Inc. diskutieren
Enanta Pharmaceuticals (NASDAQ:ENTA) had its price target raised by analysts at Westpark Capital from $24.00 to $28.00. They now have a "buy" rating on the stock.
Ratings data for ENTA provided by MarketBeat
Stopped prediction by Westpark_Capital for Enanta Pharmaceuticals Inc.
Enanta Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€7.60
02.09.25
02.09.25
€20.51
02.09.26
02.09.26
21.71%
22.10.25
22.10.25